Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Nova Minerals | NVA | Jan 30, 2025 | 12.28 | -3.08 |
Novabay Pharmaceuticals | NBY | Jan 30, 2025 | 0.65 | -6.00 |
Novagold Resources | NG | Jan 30, 2025 | 3.13 | +1.62 |
Novanta | NOVT | Jan 30, 2025 | 149.07 | +0.89 |
Novartis ADR | NVS | Jan 30, 2025 | 104.75 | +1.77 |
Novavax | NVAX | Jan 30, 2025 | 9.01 | +2.27 |
Novo Nordisk ADR | NVO | Jan 30, 2025 | 85.34 | +1.56 |
NovoCure | NVCR | Jan 30, 2025 | 25.51 | -0.04 |
Novonix ADR | NVX | Jan 30, 2025 | 1.46 | -2.67 |
NPK International | NPKI | Jan 30, 2025 | 7.21 | 0.00 |
NRG Energy | NRG | Jan 30, 2025 | 105.00 | +4.40 |
NRx Pharmaceuticals | NRXP | Jan 30, 2025 | 2.99 | -4.78 |
NSTS Bancorp | NSTS | Jan 30, 2025 | 12.05 | 0.00 |
Nu Holdings | NU | Jan 30, 2025 | 13.44 | +7.09 |
Nu Skin Enterprises | NUS | Jan 30, 2025 | 6.93 | +0.43 |
Nuburu | BURU | Jan 30, 2025 | 0.31 | -11.74 |
NuCana ADR | NCNA | Jan 30, 2025 | 1.03 | -7.21 |
Nucor | NUE | Jan 30, 2025 | 128.68 | +1.43 |
Nukkleus | NUKK | Jan 30, 2025 | 26.36 | +3.01 |
Nurix Therapeutics | NRIX | Jan 30, 2025 | 20.02 | +1.86 |
NuScale Power | SMR | Jan 30, 2025 | 23.58 | +7.18 |
Nutanix A | NTNX | Jan 30, 2025 | 68.01 | +0.37 |
Nutex Health | NUTX | Jan 30, 2025 | 47.86 | +6.88 |
Nutriband | NTRB | Jan 30, 2025 | 7.90 | +8.07 |
Nutrien | NTR | Jan 30, 2025 | 52.32 | -1.45 |
Nuvalent A | NUVL | Jan 30, 2025 | 87.75 | +2.61 |
Nuvation Bio A | NUVB | Jan 30, 2025 | 2.40 | -0.83 |
Nuvectis Pharma | NVCT | Jan 30, 2025 | 6.74 | +5.81 |
Nuveen Amtfree Municipal Credit Income Fund | NVG | Jan 30, 2025 | 12.48 | +0.48 |
Nuveen Amtfree Municipal Value Fund | NUW | Jan 30, 2025 | 13.73 | +0.22 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.